Takeda Pharmaceutical Co Ltd (TAK)
13.28
-0.14
(-1.01%)
USD |
NYSE |
Dec 16, 16:00
13.28
0.00 (0.00%)
After-Hours: 20:00
Takeda Pharmaceutical Shareholders Equity (Quarterly): 48.46B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| HUTCHMED (China) Ltd | 740.08M |
| Astellas Pharma Inc | 10.54B |
| Nxera Pharma Co Ltd | 428.64M |
| PeptiDream Inc | 365.20M |
| Healios KK | 20.16M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 102.04B |
| Total Liabilities (Quarterly) | 53.58B |
| Debt to Equity Ratio | 0.7299 |
| Current Ratio | 1.279 |
| Net Debt Paydown Yield | -1.15% |